IAM
GILD icon

ICM Asset Management’s Gilead Sciences GILD Stock Holding History

ICM Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,250
Closed -$666K – 57
2016
Q1 		$666K Sell
7,250
-630
-8% -$56.8K 1.04% 35
2015
Q4 		$797K Sell
7,880
-300
-4% -$31.2K 1.17% 35
2015
Q3 		$803K Sell
8,180
-7,855
-49% -$872K 1.29% 38
2015
Q2 		$1.88M Buy
16,035
+4,405
+38% +$481K 1.95% 18
2015
Q1 		$1.14M Buy
11,630
+4,240
+57% +$431K 1.27% 35
2014
Q4 		$697K Sell
7,390
-80
-1% -$8.27K 0.71% 50
2014
Q3 		$795K Sell
7,470
-575
-7% -$56.3K 0.86% 45
2014
Q2 		$667K Buy
+8,045
New +$626K 0.63% 55

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ICM Asset Management's GILD Position: Q2 2016 in Review

ICM Asset Management sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 7,250 shares — an estimated $666K sold.

ICM Asset Management first reported a position in GILD in Q2 2014 and held it in 8 quarters. The position peaked at $1.88M in Q2 2015. 1,596 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • ICM Asset Management reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • ICM Asset Management sold 7,250 Gilead Sciences shares in Q2 2016, an estimated $666K.
  • ICM Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 8 quarters.
  • ICM Asset Management's Gilead Sciences position peaked at $1.88M in Q2 2015.
  • 1,596 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on ICM Asset Management's 13F filing for Q2 2016, filed 29 Jul 2016.